• Users Online: 99
  • Print this page
  • Email this page

Table of Contents
Year : 2021  |  Volume : 14  |  Issue : 4  |  Page : 154-162

Surgical and endoscopic treatment of pulmonary tuberculosis: A report from russia

Department of Pathology, Peoples' Friendship University of Russia, Moscow, Russia

Date of Submission22-May-2021
Date of Decision27-Jun-2021
Date of Acceptance14-Oct-2021
Date of Web Publication11-Jan-2022

Correspondence Address:
Sergei V Jargin
Department of Pathology, Peoples' Friendship University of Russia, Moscow
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/hmj.hmj_29_21

Rights and Permissions

Introduction: This article is a narrative review of Russian-language publications on surgical and endoscopic methods applied for tuberculosis in comparison with the international literature. Methods: Search of the international literature was performed predominantly using PubMed. Russian-language professional publications were searched for in the internet and the electronic library of eLIBRARY.ru. Results: After the introduction of efficient drug therapy in the 1950–1960s, surgical treatment of tuberculosis has been partly abandoned in many parts of the world. The role of surgery remains controversial. Priority of the former Soviet Union in this field was pointed out. Besides, the use of bronchoscopy in tuberculosis is briefly overviewed as well as the treatment of patients with alcoholism. Clinical recommendations are not the goal of this paper. The message is that patients should not undergo surgery and other invasive procedures without evidence-based indications. The patients must be objectively informed about potential benefits and risks to be able to make an independent decision according to the principle of informed consent. Conclusion: The factors contributing to the persistence of suboptimal practices included the authoritative management style, disregard for the rules of scientific polemics and insufficient use of foreign literature. Thanks to the Internet, the foreign literature is used increasingly today. However, some papers containing questionable recommendations have remained without due commentaries, so that persistence of suboptimal practices or reversion to them is not excluded.

Keywords: Bronchoscopy, lung resection, surgery, tuberculosis

How to cite this article:
Jargin SV. Surgical and endoscopic treatment of pulmonary tuberculosis: A report from russia. Hamdan Med J 2021;14:154-62

How to cite this URL:
Jargin SV. Surgical and endoscopic treatment of pulmonary tuberculosis: A report from russia. Hamdan Med J [serial online] 2021 [cited 2023 Mar 30];14:154-62. Available from: http://www.hamdanjournal.org/text.asp?2021/14/4/154/335378

  Introduction Top

After the introduction of efficient drug therapy in the 1950–1960s, the surgical treatment of tuberculosis (Tb) has been partly abandoned in many parts of the world.[1] The role of surgery remains controversial.[1],[2] The priority of the former Soviet Union (SU) in this field was pointed out.[3],[4] The rapid development of Tb surgery took place in 1947–1960 and thereafter.[5] The Tb surgery has been applied not only in large centres but also in numerous peripheral hospitals.[5],[6] This development has been associated with the names of Lev Bogush (1905–1994) and Mikhail Perelman (1924–2013).[5],[6],[7],[8],[9] According to Bogush, 'surgery must occupy the leading position in the integral Tb treatment instead of being a last resort for cases of ineffective drug therapy'.[6] He claimed that even severe respiratory insufficiency is not a contraindication for lung resection.[8] Perelman became director of the Institute for Phthisiopulmonology at the I. M. Sechenov Moscow Medical Academy in 1998 and in the following year's editor-in-chief of the 'Tuberkulez i Bolezni Legkikh' (tuberculosis and lung diseases), the leading Russian specialist journal. It was time when the World Health Organization (WHO) promoted the directly observed treatment, short-course (DOTS) programme in Russia. Perelman called this WHO programme absurd, insisting that surgery must be applied in the Tb treatment more often.[9] In this connection, the aim of this review is to point out that patients should not undergo surgery and other invasive procedures to comply with doctrines without bonafide clinical indications.

  Methods Top

This article is a narrative review of Russian-language publications on surgical and endoscopic methods applied for tuberculosis in the former SU in comparison with the international literature. The search of international literature was performed using PubMed. Russian-language professional publications were searched in the Internet, in libraries and the electronic database eLIBRARY.RU. The data from the literature have been reviewed and synthesized on the basis of the author's observations since 1980.

  Surgical Treatment Top

From 1973 through 1987, 285,000 patients with pulmonary Tb were operated on in the former SU, in 1987 – 26,000, whereas 85% of the operations were lung resections.[10] In the period 1986–1988, 17,000–18,000 operations for pulmonary Tb were performed in the Russian Soviet Republic (part of the former SU) yearly only in specialised phthisiological hospitals.[3] The incidence of Tb in 1986 and 1988 was, respectively, 43.8 and 40.8 per 100,000 inhabitants.[11] Taking into account the population of Russia, ≥29 surgeries for every 100 newly diagnosed Tb cases were performed in those years. In 2003, 10,479 surgeries (9 per 100 new cases) were performed, which was considered 'extremely insufficient'.[12] This calculation is approximate, since the data from various sources slightly differ. In any case, the decrease in surgical activity was significant [Figure 1] taking into account the reported increase in Tb incidence from 34.0 in 1991 up to 90.4 per 100,000 in 2000.[11] By analogy with other diseases,[13] an artefact can be behind the 'huge variation in Russian mortality'[14] and incidence of certain conditions, e.g., understatement of Tb morbidity during the Soviet time. In 2006, 12,286 operations were carried out for pulmonary Tb including 9300 (75.7%) lobectomies and other resections as well as 399 (3.2%) pneumonectomies.[4]
Figure 1: The ratio number of surgeries/newly diagnosed tuberculosis cases in Russia[3],[4],[11],[12] compared to other countries[22],[23],[24]

Click here to view

According to another report, the forms of Tb most frequently treated by resections and pneumonectomies were cavitary Tb (52.2%) and tuberculoma (43.9%).[15] The above-named surgeries were performed and recommended also for patients with inactive post-tuberculous fibrosis including cases with sparse symptoms.[16] At the same time, surgeries were performed in active disseminated Tb.[17] In some provinces (Kemerovo, Chelyabinsk and Mordovia), 25%–40% of patients with destructive Tb were operated on.[18] At the time of initial Tb diagnosis, an operation was deemed indicated in 15%–20% of patients;[3] according to another paper by the same authors, indications for surgery were found in 20%–30% of patients at the time of initial diagnosis and/or amongst cases of active Tb.[19] In Yekaterinburg and the surrounding province (2006–2008), indications for surgery were found in 1784 from 4402 (40.5%) patients with pulmonary Tb, whereas 1079 (24.5%) were operated on. The comparatively low surgery rate was explained by the patients' non-compliance and unavailability.[20] According to the last (2020) edition of the Phthisiology textbook, 6.1%–6.7% of Tb patients are currently operated on in Russia; however, 'in some regions that have actively cooperated with the M. I. Perelman Institute for Phthisiopulmonology…, the percentage has been several times higher'.[21] In the international literature, corresponding figures are generally ≤5%.[22],[23],[24] Tb surgery may become more topical due to the multidrug resistance. According to a current estimate from Russia, the need for surgery has increased up to 15% over the last 20 years.[25] However, the recent systematic review and meta-analysis concluded that, compared with the chemotherapy alone, the survival benefit of pulmonary resection combined with chemotherapy is not significant, although the quality of data was deemed 'relatively poor'.[26] According to another meta-analysis, partial lung resection, but not pneumonectomy, was associated with the treatment success in multidrug-resistant Tb. It was not excluded, however, that 'healthier' patients were preferentially chosen for surgery, causing a bias.[1] The confounding by indication, as patients most likely to benefit are selected for the treatment, has been a limitation in many studies.[1],[27] Despite the lack of clinical trial data on efficacy of adjunctive surgical therapy, countries of the former SU have continued to perform many surgical interventions, mainly resections.[27],[28]

Tuberculoma (>2 cm, also in children) has been generally regarded as an indication for surgery.[21],[29] The same experts designated fibrocavitary Tb as an absolute indication for surgery.[21] Tuberculomas >1 cm were routinely operated on,[30],[31],[32] which is generally at variance with the international practice.[33],[34],[35] Indications per se are beyond the scope of this review. There has been an opinion since the 1950s that potential instability of tuberculoma does not justify thoracic surgery and that asymptomatic patients with an unchanging solid focus do not require treatment. Tuberculoma as an indication for pulmonary resection was seen differently from other forms of Tb where surgical risks could be justified by a poorer prognosis.[36] Nevertheless, tuberculoma was the most frequent indication for lung surgery in Tb patients at the I. M. Sechenov Medical Academy (44.2%),[4] while at other institutions, this percentage has been up to 50%–80%.[35] In particular, tuberculoma was the most frequent indication for surgery in adolescent Tb patients.[29] Children were routinely operated for tuberculomas, non-specific inflammatory, fibrotic lesions and bronchiectasis;[37] more references are in the preceding review.[38] The surgical treatment of tuberculoma was officially recommended also for cases with extensive lesions in remaining pulmonary tissue.[39] Bilateral resections were performed for various forms of Tb including solitary tuberculomas on both sides.[40],[41],[42] A study from the above-mentioned Institute for Phthisiopulmonology reported 771 lung surgeries, performed in 700 Tb patients with drug resistance, up to 4 operations pro patient. Post-operative complications were observed in 100 cases (12.9%) and fatal outcomes in 12 (1.5%).[43] Another example from the same institution: Amongst 60 operated Tb patients (16 pneumonectomies, 24 lobectomies and smaller resections), the complication rate was 37%, mortality – 5%; 18.3% were discharged from the hospital with persisting complications.[44]

Resections were performed for tuberculoma, infiltrative and cavitary Tb without preceding medical treatment or within 1 month after the diagnosis, i.e. when medical therapy could have been efficient.[31],[45] One of the arguments in favour of the early surgery was the non-compliance increasing with time,[31] apparently, as the patients collected more knowledge about their disease and advice from other patients. In diabetes mellitus, a surgery was recommended for tuberculoma after 2–5 months of medical therapy. The authors operated also on asymptomatic patients and recorded an overall 15.73% rate of complications.[46] Apparently, complication rates have been sometimes underestimated, e.g., due to a limited follow-up. Lung surgeries for Tb were performed and recommended also for aged patients with comorbidities.[47],[48],[49],[50] Sokolov found indications for surgery in 210 from 289 (72.6%) 50–73-year-old Tb patients and operated 180 (62.2%) of them, 144 operations being lung resections. Amongst the latter 144 patients, 93 (66.4%) had cavitary disease and 43 (30.8%) – tuberculoma. Reactivation of Tb early after the surgery was noted in 8.6%, fistula – 27.2%, atelectasis or incomplete lung re-expansion – 20%, pneumonia – 5.7%, pleural empyema – 3.6% and other complications – 12.9% of cases; 8 (5.7%) patients died after the surgery.[48] In his monograph based on 233 lung resections in Tb patients older than 50 years (mortality 5.4%), the author reasonably concluded that 'it is important that a surgery would not accelerate an unfavorable outcome'.[47] According to another report, tuberculoma was the most common indication, and lobectomy – the most frequent technique in elderly Tb patients, whereas epidemiological considerations, i.e., potential contagiosity, were amongst arguments in favour of the surgical treatment.[50] Statements of this kind can be found also in recent papers, e.g., 'Surgery in patients with tuberculomas is recommended to reduce their infectiousness'.[25] Note that tuberculoma is infrequently contagious.[25] In the author's opinion, potential contagiosity does not justify a thoracic surgery. In any case, patients must be comprehensively informed about potential benefits and risks to be able to make an independent decision according to the principle of informed consent.

Bilateral resections were performed in various Tb forms including solitary tuberculomas on both sides[8],[40],[41],[42],[51] or tuberculoma and cancer.[52] Indications for a second lung surgery were found in 20%–37% of previously operated cases.[53] The following report is of interest. Out of 1311 Tb patients operated in one institution in the period 1989–2001, 241 developed relapses. After excluding 8 patients with contraindications, indications for second surgery were found in 84 out of 241 (35%) previously operated patients.[53] Post-operative relapses of Tb were regarded as indications for repeated surgeries up to a 'concluding pneumonectomy'[41] and resections of the single lung.[51] For example, repeated resections on both sides with a subsequent pneumonectomy were performed in one patient along with 52 bronchoscopies (Bs).[54] As mentioned above, the lung resection or pneumonectomy was deemed applicable even in cases with severe respiratory insufficiency.[6],[8],[51],[55] Bilateral resections or pneumonectomy plus contralateral 'economic' (sparing) resection was regarded indicated for patients with a Tb lesion on one side and non-specific inflammatory and/or fibrotic lesion on the other side.[56]

It should be noted in conclusion of this section that pulmonary resections and pneumonectomies for Tb were performed also in the former GDR. Indications for surgery were more limited than discussed above; they were ascertained after chemotherapy and stabilisation of the disease. Active contralateral foci were considered to be contraindications.[57] Mainly small case series were reported.[57],[58],[59] Of note, amongst 502 surgical cases (81 pneumonectomies, 266 lobectomies and 155 segmental resections), there were only 3 tuberculomas.[60] In 1965, results of a study were published reporting a decline in the vital capacity of the lungs after such operations.[61] A tendency of a decrease in the frequency of resections for Tb was noticed.[60],[62],[63] Today, surgical procedures for pulmonary tuberculosis are highly selective.[64]

  The Comorbidity of Tuberculosis and Alcoholism Top

According to official instructions, indications for surgery were more frequent in alcoholics than in other Tb patients.[65] In the case of alcoholism, the surgical treatment was recommended to be implemented earlier, i.e., after a shorter period of medical therapy.[32] Amongst other things, vocal cord injuries were observed after repeated Bs sometimes performed in conditions of suboptimal procedural quality assurance. It was noticed that vigorous apomorphine-induced vomiting as emetic or aversive therapy of alcohol dependence provoked haemoptysis.[66] The following treatments were applied to alcoholics: prolonged intravenous infusions, sorbent haemoperfusion, pyrotherapy with sulfozine (oil solution of sulphur for intramuscular injections), endoscopic and surgical biopsies of internal organs, sometimes without clear indications also for research.[67],[68],[69],[70],[71],[72] Infusions for the purpose of detoxification were generally recommended for patients with alcoholism including moderately severe withdrawal syndrome.[67],[71],[72],[73] The recommended duration of detoxification was 10–12 days.[67] The latter included intravenous drip infusions of solutions: sodium and calcium chloride, magnesium sulphate, glucose, dextran, etc., (7–10 infusions daily). This is at variance with the international literature. Alcohol and its metabolites are eliminated spontaneously while rehydration can be usually achieved per os. Intravenous glucose and magnesium are generally not recommended for patients with alcohol withdrawal syndrome.[74],[75] Excessive infusions of magnesium-containing solutions are associated with adverse effects also in alcoholics.[76] Furthermore, the detoxification of alcoholics included intramuscular injections of 25% magnesium sulphate solution together with 40% glucose, 10% calcium chloride and 30% sodium thiosulphate solutions and subcutaneous infusions of up to 1 L of isotonic saline.[65],[67],[77] Some patients considered such treatments as punishments. In conditions of suboptimal procedural quality assurance, repeated infusions and endovascular and endoscopic manipulations can lead to the transmission of viral hepatitis, which was known to occur in some treated alcoholic patients.

  Compulsory Hospitalisation and Treatment Top

The compulsory treatment was endorsed by regulations;[67] more details and references are in the review.[70] Reportedly, in 1994, about 60% of patients of one of the 'phthisio-narcological' institutions for compulsory treatment escaped while a half of them were brought back by the police (militia).[78] The duration of compulsory treatment in such institutions was around 1 year or longer.[67] In 1974, chronic alcoholism was officially declared to be a ground for compulsory treatment; the regulation was made stricter in 1985, making the forced hospitalisation and treatment of chronic alcoholics independent of antisocial behaviour. This practice has been designated in 1990 as contradictory to human rights.[79] The system of compulsory treatment for Tb was partly dismantled during the 1990s, but some experts recommended its restoration and further development.[80],[81]

The outpatient treatment of Tb, usual in other countries, was supposed to be hardly applicable in Russia.[82] According to the Governmental Ordinance No. 378 of 16 June 2006, patients with contagious Tb are not allowed to live in one apartment with other people. As said by the Federal Law No. 77 'Prevention of the spread of Tb in Russia' of 18 June 2001 (amended 2013), 'patients with contagious forms of Tb, repeatedly violating the sanitary and anti-epidemic regimen, as well as those deliberately evading examinations for Tb or (emphasis added) the treatment of Tb, are hospitalized into phthisiological institutions for obligatory examination and treatment by court decisions'. It is stipulated by the same Law that the principle of informed consent is not applicable in this connection. A survey conducted across Russian phthisiological institutions found >6000 legal proceedings in the period 2004–2008 whereas 3163 Tb patients were hospitalised after court decisions.[80] For example, in the study from the Kemerovo province, 463 court cases resulted in 421 decisions to compulsorily hospitalise Tb patients.[81] There are administrative and legal mechanisms, e.g., hospitalisation of Tb patients with the help of police and criminal prosecution in the case of non-compliance. Amongst others, the latter pertains to non-contagious Tb in patients released from jail.[83] Compulsory treatments are generally at variance with the international literature and regulations. According to the WMA International Code of Medical Ethics, 'A physician shall respect a competent patient's right to accept or refuse treatment'. It was noted in regard to Tb that neither the statutory exceptions to the principle of consent nor the conditions of 'required care' allow legally binding measures against patients refusing a treatment or isolation.[84] The informed consent for invasive procedures and chemotherapy is of particular importance in conditions where an overtreatment is not excluded.[38],[85],[86] The author agrees to the viewpoint that informed consent is grounded in the principle of bodily integrity, thus being not obligatory for non-invasive procedures such as sputum samples collected through expectoration; more discussion is in the reference.[87] Excessively rigorous interpretations of the informed consent are potentially harmful as they put non-invasive tests into one ethical category with invasive manipulations potentially resulting in less responsible attitude to both.[88]

  Bronchoscopy Top

Bs has been applied in all forms of Tb in adults and children also when Tb was suspected.[89],[90],[91],[92],[93],[94],[95],[96] It was recommended for young patients with 'hyperergic' (high degree of hypersensitivity) tuberculin tests[97] or within the diagnostic algorithm for suspected Tb in smear-negative cases.[98] After a detection of mycobacteria, an urgent hospitalisation and examination including Bs has been recommended.[98] Primary Tb was regarded as an indication for Bs in children.[99] In the recent (2021) Russian-language handbook of paediatric pulmonology, 'suspected Tb' is listed amongst indications for Bs.[100] Bs was designated as one of the main diagnostic methods in focal non-destructive Tb.[101] In destructive (cavitary) Tb, repeated therapeutic Bs (1–2 weekly during 2–4 months) were recommended by the Ministry of Health.[102] Some researchers used Bs as a second step of the screening for Tb in children.[103] Therapeutic Bs and bronchoscopic monitoring has been applied in pulmonary Tb also with non-specific bronchial lesions.[104],[105],[106] An example: 22,469 Bs were performed in 5195 patients from 1994 through 2013 (1123 Bs yearly on average), including 1766 (34%) patients older than 65 years, at a phthisiological hospital in Moscow (705–1225 beds at different times; 368 surgeries performed in 2013).[107],[108] In particular, some military doctors performed many Bs, e.g., 1478 procedures in 977 young people (19.5 ± 0.1 years old),[109] as well as in other patients diagnosed with community-acquired pneumonia.[110],[111],[112]

Bs with questionable indications has been reviewed previously.[38],[113] Indications for Bs are beyond the scope of this review. Undoubtedly, fibre-optic Bs is a useful method in the diagnosis of pulmonary Tb.[114] Outside the former SU, Bs has not been routinely performed in all Tb patients.[115] There is an opinion that in children, Bs is usually unnecessary, although the procedure may be useful in diagnosing endobronchial TB.[116],[117] Bs does not usually improve the sensitivity of microbiological diagnostics compared to gastric aspirates and induced sputum testing,[117],[118],[119],[120],[121],[122] although there is another opinion.[114] As endobronchial Tb can mimic cancer, Bs and biopsy plays an important role in the differential diagnosis. In this connection, Bs is complementary to computed tomography (CT), which can assess the bronchial wall involvement and lumen patency. In particular, the multiple detector CT with the imaging technique such as 'virtual Bs' is a diagnostic method for central airway lesions.[123] Reportedly, CT determined the cause of bleeding more often than Bs, whereas both methods were comparably sensitive in identifying the bleeding site.[124] Some experts suggested that CT can replace Bs in certain cases, e.g., as the first-line diagnostic procedure for massive haemoptysis.[124] Replacing Bs with induced sputum testing for mycobacteria removes Bs-related risks including that of nosocomial infection.[125] Of note, endoscopy is amongst the risk factors of infections such as viral hepatitis.[126] Not surprisingly, the incidence of hepatitis B was reported to be five times higher in Tb patients than in the population of Russia.[127] The enhanced frequency of viral hepatitis or its markers in Tb patients including children was reported.[128] Outbreaks of infections occurred after endoscopy.[129],[130],[131] Reportedly, mycobacteria were the greatest obstacle to the infection control in Bs units.[131] It has been suggested that Bs may spread infection within the lung, from one patient to another, and – by inducing coughing – cause airborne infections of other people.[132]

  Surfactant Therapy Top

The surfactant (Sf) therapy of pulmonary diseases (Tb, acute respiratory distress syndrome, pneumonia, etc.), excluding neonatal respiratory distress syndrome (RDS), and Bs as the delivery method, have been discussed previously.[133],[134],[135],[136] Sf-BL from bovine lungs has been developed and registered in Russia. The manufacturing method is described in the patent[137] (partly translated[133],[134]), where it is stated that Sf-BL contains ~2% of protein. Endobronchial instillations of xenogeneic proteins may cause immune reactions.[138] In older patients, a more pronounced immune response can be expected than in premature infants with RDS. Endobronchial instillations of porcine Sf led to an increase in the eosinophilic inflammation in patients with bronchial asthma.[139] St-BL was used in asthma, bronchitis, pneumonia, chronic obstructive pulmonary diseases and Tb (references are in the review and patent[137],[140]), as well as in COVID-19,[141] where immune and inflammatory reactions might contribute to the 'cytokine storm' and collagen synthesis. Bs was used as the delivery method of Sf preparations[140],[141],[142],[142],[143],[144],[145],[146],[147],[148],[149] with bronchial biopsies,[149] while some other studies used inhalations. Both inhalations and Bs have been used in Tb.[149],[150] Sf-BL was recommended by an official letter of the Ministry of Health for the treatment of viral pneumonia.[151] This letter refers to the manufacturer's instruction, where it is stated that the optimal method of the Sf delivery is Bs with an instillation into individual segmental bronchi.[152] No comparable recommendations have been found in the literature. Until recently, Oleg Rosenberg had been director of the manufacturing firm Biosurf (https://biosurf.ru/). No conflicts of interest have been declared in his publications. Misquoting was found in the Rosenberg's papers on Sf.[135],[136] Here follow several examples from the last Russian-language review: 'A number of studies have shown an improvement in oxygenation, a decrease in the time spent on mechanical ventilation and an increase in survival'.[140] In the cited publications, the conclusions are different, e.g., 'This pilot study presents preliminary evidence that Sf might have therapeutic benefit for patients with ARDS'.[153] Furthermore: '… Sf-BL reduces mortality in adults with ARDS 3–4-fold'.[140] There are no such statements in the cited source.[154] 'Deficiency of pulmonary Sf or changes in its composition have been described not only in neonatal RDS, but also in … pulmonary Tb and other diseases'.[140] A Russian-language handbook is cited,[155] where tuberculosis is not mentioned on the indicated pages 167–181. Finally, '… these data can serve as the basis for multicenter randomized clinical studies of the efficacy of CHF5633 for the treatment of ARDS'.[137] In the cited publication,[156] ARDS is not mentioned. We checked some references from other articles by the same author: 'Results of the phase II multicenter randomized clinical trials and pilot studies of the efficacy of natural Sf preparations in the treatment of ARDS showed a significant improvement in oxygenation, decreased mechanical ventilation time and decreased mortality'.[157] One of the cited studies reported that the treatment of asthmatic patients with a porcine Sf preparation resulted in an augmentation of the eosinophilic inflammation after allergen challenge. The authors concluded that the treatment is not suitable to decrease the allergic response in asthmatic patients, which might also pertain to other animal-derived Sf preparations.[139] In another cited publication, the effectiveness of St-therapy in asthmatic children was not confirmed.[158] References about Tb in the article[157] are self-citations.[150],[159] From another article by the same author: 'It is believed that disturbances in the pulmonary Sf system can be the cause of bronchial obstruction, mucosal edema and increased fluid secretion into the bronchial lumen'.[160] The cited publication was not found; an article with a similar title does not contain such statements but the following: 'Although there is no direct proof that surfactant dysfunction in human asthma causes airway obstruction, the above-mentioned and published data from the literature support the concept that poor functioning surfactant contributes to the pathophysiological scenario in asthma'.[161] There are also other incorrect citations. Some studies from Russia have reported that inhalations of Sf improve the effectiveness of the anti-Tb therapy, significantly accelerating healing, dissolution of specific Tb infiltrations and closing of caverns, while Mycobacterium tuberculosis disappeared from sputum at an early date.[150],[159],[162],[163] No similar reports have been found in the international literature. Finally, intravenous injections of stem cells to Tb patients[164],[165] should be mentioned together with a warning against the use of Bs without proven clinical indications.

  Conclusion Top

The role of surgery in Tb remains controversial. Clinical recommendations are not the goal of this review. The central message is that patients should not undergo surgeries, bronchoscopies and other invasive procedures merely to comply with instructions and doctrines without sufficient evidence-based indications, potentially fed by motives such as personnel training, e.g., of military surgeons and endoscopists. The approach should be individual based on a consensus expressed in the international literature. The principle of informed consent must be observed – patients objectively informed on potential benefits and risks to be able to make an independent decision. The informed consent began only recently to be mentioned in papers from the former SU reporting research using invasive methods, e.g., bronchoscopic study of childhood asthma, where the consent of parents was regarded to be sufficient.[166] Note that the principle of informed consent or assent is applicable also to adolescents and children.[167],[168] Even today, patients are sometimes requested to sign in advance a form certifying their blanket consent to unnamed diagnostic and therapeutic procedures. The factors contributing to the persistence of suboptimal practices included the authoritative management style, disregard for the rules of scientific polemics, insufficient use and occasional misquoting of the foreign literature and absence of many internationally used handbooks even in central medical libraries.[169] Thanks to the Internet resources, the foreign literature is used increasingly. However, some papers containing questionable recommendations have remained without due commentaries, so that a persistence of suboptimal practices or reversion to them is not excluded. Other invasive procedures applied with questionable indications have been overviewed previously.[38],[85],[86],[113]

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, et al. Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: An individual patient data metaanalysis. Clin Infect Dis 2016;62:887-95.  Back to cited text no. 1
WHO. The Role of Surgery in the Treatment of Pulmonary Tuberculosis and Multidrug-and Extensively Drug-Resistant Tuberculosis. Geneva: World Health Organization Regional Office for Europe; 2014.  Back to cited text no. 2
Perel'man MI. Surgery of pulmonary tuberculosis. Probl Tuberk 1998;3:27-32.  Back to cited text no. 3
Ots ON, Sinitsyn MV, Semenov GI, Latyshev AN, Agkatsev TV, Kessel' MM. Surgery for respiratory tuberculosis at the Research Institute of Phthisiopulmonology, I. M. Sechenov Moscow Medical Academy: History and current trends. Tuberk Biolezni Legkih 2009;12:11-21.  Back to cited text no. 4
Kucherov AL. Main developmental steps of the phthisiatric surgery in the RSFSR. In: Problems of the Lung Surgery (to the 70th Anniversary of Prof. Lev Bogush). Moscow: Central Institute of Tuberculosis; 1975. p. 93-9.  Back to cited text no. 5
Bogush LK, Kalinichev GA. Corrective operations at lung resections. Tbilisi: Sabchota Sakartvelo; 1979.  Back to cited text no. 6
Perelman MI. 60 Years in Medicine. Facts without Commentaries. Moscow; 2004.  Back to cited text no. 7
Bogush LK, Kariev TM, Eshankhanov M. Surgery of Severe forms of Pulmonary Tuberculosis. Tashkent: Meditsina; 1983.  Back to cited text no. 8
Lichterman B. Mikhail Izrailevich Perelman. BMJ 2013;346:f3042.  Back to cited text no. 9
Perelman MI, Streltsov VP, Naumov VN. Clinical and social aspects of organ-preserving lung surgery in tuberculosis. In: Organ-Preserving Operations in Phthisio-pulmonology. Moscow: Scientific Center for Phthisio-Pulmonology; 1989. p. 4-6.  Back to cited text no. 10
Nechaeva OB. Tuberculosis situation in Russia. Tuberk Biolezni Legkih 2018;8:15-24.  Back to cited text no. 11
Shilova MV, Khruleva TS, Tsybikova EB. Surgical aid to patients with respiratory tuberculosis. Probl Tuberk Bolezn Legk 2005;5:31-6.  Back to cited text no. 12
Jargin SV. Cardiovascular mortality trends in Russia: Possible mechanisms. Nat Rev Cardiol 2015;12:740.  Back to cited text no. 13
Leon DA, Chenet L, Shkolnikov VM, Zakharov S, Shapiro J, Rakhmanova G, et al. Huge variation in Russian mortality rates 1984-94: Artefact, alcohol, or what? Lancet 1997;350:383-8.  Back to cited text no. 14
Kibrik BS, Bukharin PA. Rehabilitation of patients following pulmonary resections for tuberculosis. Probl Tuberk 1976;12:43-7.  Back to cited text no. 15
Kiseleva IA. Clinical aspects and results of surgical treatment of metatuberculous changes of the lungs. Probl Tuberk 1976;12:31-5.  Back to cited text no. 16
Meladze GD. On the lung resection in extended tuberculosis. In: Problems of the Lung Surgery (to the 70th anniversary of Prof. Lev Bogush). Moscow: Central Institute of Tuberculosis; 1975. p. 406-10.  Back to cited text no. 17
Priimak AA. Significance of surgical methods in the combined therapy of tuberculosis. In: Organ-preserving Operations in Phthisio-Pulmonology. Moscow: Scientific Center for Phthisio-Pulmonology; 1989. p. 7-8.  Back to cited text no. 18
Perel'man MI, Naumov VN, Dobkin VG, Strel'tsov VP, Dubrovskiĭ AV. Indication for the surgery in patients with pulmonary tuberculosis. Probl Tuberk 2002;2:51-5.  Back to cited text no. 19
Motus IY, Skorniakov SN, Golubev DN, Karskanova SS, Malceva AS. Surgical treatment of pulmonary tuberculosis. J Ural Med Acad Sci 2009;3:103-6. Available from: https://www.elibrary.ru/item.asp?id=12877524. [Last accessed on 2021 Nov 14]  Back to cited text no. 20
Giller DB, Mishin VI. Phthisiology. Moscow: Geotar-Media; 2020.  Back to cited text no. 21
Olcmen A, Gunluoglu MZ, Demir A, Akin H, Kara HV, Dincer SI. Role and outcome of surgery for pulmonary tuberculosis. Asian Cardiovasc Thorac Ann 2006;14:363-6.  Back to cited text no. 22
Dewan RK, Pezzella AT. Surgical aspects of pulmonary tuberculosis: An update. Asian Cardiovasc Thorac Ann 2016;24:835-46.  Back to cited text no. 23
Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: An individual patient data metaanalysis of 9,153 patients. PLOS Med 2012;9:e1001300.  Back to cited text no. 24
Yablonskii PK, Kudriashov GG, Avetisyan AO. Surgical resection in the treatment of pulmonary tuberculosis. Thorac Surg Clin 2019;29:37-46.  Back to cited text no. 25
Roh HF, Kim J, Nam SH, Kim JM. Pulmonary resection for patients with multidrug-resistant tuberculosis based on survival outcomes: A systematic review and meta-analysis. Eur J Cardiothorac Surg 2017;52:673-8.  Back to cited text no. 26
Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM. Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 2012;12:157-66.  Back to cited text no. 27
Benito P, Vashakidze S, Gogishvili S, Nikolaishvili K, Despuig A, Tukvadze N, et al. Impact of adjuvant therapeutic surgery on the health-related quality of life of pulmonary tuberculosis patients. ERJ Open Res 2020;6:1-11.  Back to cited text no. 28
Giller DB, Martel II, Baryshnikova LA. Surgery of Tuberculosis in Children. Moscow: Aldi-Print; 2016.  Back to cited text no. 29
Uspenskiĭ LV, Romanychev IuA, Kodolova IM, Chistov LV, Ablitsov IuA. Diagnosis and treatment of pulmonary tuberculomas. Khirurgiia (Mosk) 1986;5:11-5.  Back to cited text no. 30
Gur'ianov VN, Strel'tsov VP, Al'ba MN. Early surgical treatment of new restrictive forms of pulmonary tuberculosis. Probl Tuberk 2000;6:48-51.  Back to cited text no. 31
Pilipchuk NS, Kharchenko EF, Ivaniuta OM. Tuberculoma of the lungs, pleura and mediastinum. Kiev: Zdorov'ia; 1974.  Back to cited text no. 32
Xia Z, Qiao K, He J. Recent advances in the management of pulmonary tuberculoma with focus on the use of tubeless video-assisted thoracoscopic surgery. J Thorac Dis 2017;9:3307-12.  Back to cited text no. 33
Ishida T, Yokoyama H, Kaneko S, Sugio K, Sugimachi K, Hara N. Pulmonary tuberculoma and indications for surgery: Radiographic and clinicopathological analysis. Respir Med 1992;86:431-6.  Back to cited text no. 34
Valiev RS, Valiev NR, Iksanov IY, Filatova MS. Epidemical importance of lung tuberculoma, the efficiency of their surgical and non-surgical treatment based on data from the Republic of Tatarstan. Probl Tuberk Bolezn Legk 2014;:18-21.  Back to cited text no. 35
Moyes EN. Tuberculoma of the lung. Thorax 1951;6:238-49.  Back to cited text no. 36
Slepukha IM. The use of surgical treatment of pulmonary tuberculosis in the age aspect. In: Problems of the Lung Surgery (to the 70th Anniversary of Prof. Lev Bogush). Moscow: Central Institute of Tuberculosis; 1975. p. 127-34.  Back to cited text no. 37
Jargin SV. Invasive Procedures with Unproven Efficiency. In: Advances in Medicine and Biology. Vol. 176, Ch. 3. Hauppauge, NY: Nova Science Publishers, Inc.,; 2021. p. 176.  Back to cited text no. 38
Methodical Recommendations. Sparing and Combined Lung Resections in Extended Forms of Tb. Tashkent: Health Ministry of Uzbek SSR; 1983.  Back to cited text no. 39
Porkhanov VA, Mova VS, Poliakov IS, Grebennikov SV, Marchenko LG. Surgical treatment of bilateral pulmonary tuberculosis. Probl Tuberk 1998;1:36-9.  Back to cited text no. 40
Repin IM. Repeated pneumonectomy in recurrence of pulmonary tuberculosis. Probl Tuberk 1990;1:35-9.  Back to cited text no. 41
Andrenko AA, Krasnov VA, Grishchenko NG. Surgical treatment of patients with advanced bilateral destructive pulmonary tuberculosis. Probl Tuberk 2000;3:32-5.  Back to cited text no. 42
Ots ON. The surgical treatment of pulmonary tuberculosis with the resistance of mycobacteria to drugs. Sechenov Medical Journal 2012;2:15-23.  Back to cited text no. 43
Kulbak VA, Lakomkin MM, Martirosjan NL. Abstract 196. The peculiarities of the surgical treatment of drug resistant pulmonary tuberculosis. In: Abstract Book. 3rd Congress of European Region, International Union against Tuberculosis and Lung diseases (IUATLD), 14th National Congress of Lung diseases. Moscow: Russian Respiratory Society; 2004. p. 55.  Back to cited text no. 44
Zyskin LI, Kozello NA, Grishin MN, Bereza RA. Early operations in pulmonary tuberculosis. Probl Tuberk 1991;3:36-8.  Back to cited text no. 45
Voloshyn IM. The indications and contraindications for the use of lung resection for tuberculoma in a diabetic patient. Klin Khir 1999;6:13-5.  Back to cited text no. 46
Govorenko GG, Sokolov SB, Slepukha IM. Surgical Treatment of Lung Diseases in Elderly Patients. Kiev: Zdorov'ia; 1975.  Back to cited text no. 47
Sokolov SB. Surgical treatment of aged tuberculosis patients. In: Problems of the Lung Surgery (to the 70th Anniversary of Prof. Lev Bogush). Moscow: Central Institute of Tuberculosis; 1975. p. 103-10.  Back to cited text no. 48
Polianskiĭ VK. The surgical treatment of pulmonary tuberculosis. Voen Med Zh 1999;320:42-5.  Back to cited text no. 49
Sokolov EA. Surgical treatment of pulmonary tuberculosis patients over 60. Probl Tuberk 1978;7:23-7.  Back to cited text no. 50
Korneevskii MD. Bilateral lung resections in tuberculosis patients. In: Problems of the Lung Surgery (to the 70th Anniversary of Prof. Lev Bogush). Moscow: Central Institute of Tuberculosis; 1975. p. 376-84.  Back to cited text no. 51
Ots ON. Bilateral lung resections. Grud Serdechnososudistaia Khir 1991;11:35-8.  Back to cited text no. 52
El'kin AV, Repin IM, Levashev IN. Surgical treatment for postoperative recurrent pulmonary tuberculosis. Probl Tuberk Bolezn Legk 2004;2:28-32.  Back to cited text no. 53
Kravchenko AF, Vinokurov II, Ivanov IuS, O-zhi-kho EA. A case of multiple operations in pulmonary tuberculosis. Probl Tuberk Bolezn Legk 2003;5:48-9.  Back to cited text no. 54
Naumov VN, Karaeva GB. Surgical treatment of patients with disseminated and progressing pulmonary tuberculosis. Probl Tuberk 1993;5:23-6.  Back to cited text no. 55
Niiazov IB. Bilateral resection in patients with tuberculosis associated with nonspecific lung diseases. Probl Tuberk 1976;12:29-31.  Back to cited text no. 56
Künstler S, Koss FH. Indication for resection in pulmonary tuberculosis in childhood and adolescence. Z Tuberk Erkr Thoraxorg 1961;117:71-92.  Back to cited text no. 57
Schwarz E, Endres G. On relations between resection therapy in pulmonary tuberculosis and pregnancy. Z Tuberk Erkr Thoraxorg 1961;117:28-36.  Back to cited text no. 58
Simon K. Special features of thoracic surgery for tuberculosis in children and adolescents . Z Tuberk Erkr Thoraxorg 1961;117:100-5.  Back to cited text no. 59
Müller RW. On our past and present therapeutic methods in the treatment of tuberculosis. Z Tuberk Erkr Thoraxorg 1965;123:64-7.  Back to cited text no. 60
Anstett F. Function tests before and after pulmonary surgery for tuberculosis. Z Tuberk Erkr Thoraxorg 1965;123:5-11.  Back to cited text no. 61
Anstett F. Surgery of the lung and pleura. Z Tuberk Erkr Thoraxorg 1968;129:53-93.  Back to cited text no. 62
Teschner M. Current indications for resection of tuberculoid lung changes - relics of the pre-chemotherapy era? Pneumologie 1998;52:80-4.  Back to cited text no. 63
Pfannschmidt J, Schönfeld N. Interdisciplinary Treatment of Patients with Pulmonary Tuberculosis. Zentralbl Chir 2017;142:S53-65.  Back to cited text no. 64
Methodical Recommendations. Special Features of Detection, Diagnosis, Clinical Course, Treatment and Prevention of Tuberculosis in Patients with Chronic Alcoholism. Kiev: Health Ministry of Ukrainian SSR; 1987.  Back to cited text no. 65
Entin GM. Treatment of Alcoholism. Moscow: Meditsina; 1990.  Back to cited text no. 66
Methodical Recommendations. Combined Treatment of Patients with Pulmonary Tuberculosis Suffering of Alcoholism. Moscow: Health Ministry of RSFSR; 1989.  Back to cited text no. 67
Makhov VM, Abdullin RG, Gitel' EL, Zavodnov VI, Podzolkov VI, Sozinova TI, et al. Visceral lesions in alcoholism. Ter Arkh 1996;68:53-6.  Back to cited text no. 68
Krut'ko VS. Pneumonia in patients with pulmonary tuberculosis and alcoholism. Probl Tuberk 1990;1:64-6.  Back to cited text no. 69
Jargin SV. Alcohol abuse and toxicity of alcoholic beverages in Russia: Recent history. ARC J Addict 2016;1:21-9.  Back to cited text no. 70
Ivanets NN, Vinnikova MA. Alcoholism. Moscow: MIA; 2011.  Back to cited text no. 71
Shabanov PD. Narcology. 2nd ed. Moscow: Geotar-Media; 2015.  Back to cited text no. 72
Altshuler VB, Rokhlina ML, Strelets NV, Darensky ID, Kravchenko SL, Utkin SI. Standards (models of protocols) for diagnostics and treatment of narcological patients. Annex to the Order of the Health Ministry of Russian Federation No. 140 of 28 April 1998. Moscow: Ministry of Health, 1998.  Back to cited text no. 73
Jesse S, Bråthen G, Ferrara M, Keindl M, Ben-Menachem E, Tanasescu R, et al. Alcohol withdrawal syndrome: Mechanisms, manifestations, and management. Acta Neurol Scand 2017;135:4-16.  Back to cited text no. 74
Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med 2014;371:2109-13.  Back to cited text no. 75
Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003;24:47-66.  Back to cited text no. 76
Ershov AI. Tuberculosis and Alcoholism. Moscow: Meditsina; 1966.  Back to cited text no. 77
Rudoĭ NM, Dzhokhadze VA, Chubakov TC, Stadnikova AV. Current status and perspectives in hospital treatment of patients with tuberculosis complicated with alcohol abuse. Probl Tuberk 1994;4:8-10.  Back to cited text no. 78
Grishko AI. The Institute of Compulsory Treatment and Occupational Re-education of Chronic Alcoholics and Drug Addicts, its Social Purpose. Moscow: Academy of the Ministry of Internal Affairs; 1991.  Back to cited text no. 79
Bogorodskaia EM, Ol'khovatskiĭ EM, Borisov SE. Legal aspects of compulsory hospitalization of incompliant patients with tuberculosis. Probl Tuberk Bolezn Legk 2009;4:8-14.  Back to cited text no. 80
Lomova LA, Kopylova IF, Smerdin SV, Chernov MT, Baeva LB, Saranchina SV. Compulsory hospitalization of non-compliant patients with tuberculosis. Tuberk Biolezni Legkih 2009;7:9-13.  Back to cited text no. 81
Bogadel'nikova IV, Sagalovich VIa, Perel'man MI. The efficacy of the ambulatory treatment of patients with newly detected pulmonary tuberculosis. Probl Tuberk 2000;5:23-8.  Back to cited text no. 82
Trifonova NI. Medical and organizational approaches to the quality enhancement of dispensary monitoring of tuberculosis patients in present conditions. Moscow: IKAR; 2010.  Back to cited text no. 83
Bouvet R, Le Gueut M. Tuberculosis and refusal of treatment: Resorting to legislation on serious health threats. Rev Mal Respir 2013;30:451-7.  Back to cited text no. 84
Jargin SV. Renal biopsy research with implications for therapy of glomerulonephritis. Curr Drug ther 2012;7:263-7.  Back to cited text no. 85
Jargin SV. Invasive procedures with questionable indications. Ann Med Surg (Lond) 2014;3:126-9.  Back to cited text no. 86
Coleman CH, Selgelid MJ, Reis A, Reichman LB, Jaramillo E. The role of informed consent in tuberculosis testing and screening. Eur Respir J 2012;39:1057-9.  Back to cited text no. 87
Jargin SV. On the use of human tissues in research and practice. J Interdiscip Histopathol 2016;4:46-7. [doi: 10.5455/jihp. 20160607021524].  Back to cited text no. 88
Kvasnitskiĭ BI, Voloshchuk EO. Frequency and nature of bronchial changes based on data from a provincial tuberculosis dispensary. Vrach Delo 1984;4:56-8.  Back to cited text no. 89
Lebedev KM, Filippov VP, Vasil'ev VIu, Bolotov PA. Use of carbon dioxide laser in the treatment of tuberculosis of the bronchi and trachea in children and adolescents. Probl Tuberk 1989;3:30-3.  Back to cited text no. 90
Bubochkin BP, Sobolev GS, Radchenko TN. The endoscopic bronchial picture of patients with pulmonary tuberculosis of various age groups. Probl Tuberk 1989;9:19-22.  Back to cited text no. 91
Belen'kiĭ MS, Balon NB. Diagnostic and therapeutic bronchoscopy under conditions of a district antituberculosis dispensary. Probl Tuberk 1977;4:45-8.  Back to cited text no. 92
Spitsyna TA, Gerasin VA, Molodtsova VP, Odintsov AI. Bronchial changes in children with primary tuberculosis. Probl Tuberk 1984;4:26-30.  Back to cited text no. 93
Chernushenko EF, Shatrov VA, Belianovskaia TI, Kuznetsova LV, Shpak OI. The function of phagocytosing cells in pulmonary tuberculosis patients. Probl Tuberk 1986;1:59-63.  Back to cited text no. 94
Nikolaev IS, Mishanov RF, Patsenker II. Early detection of tuberculosis and nontuberculous lung diseases. Probl Tuberk 1982;4:31-4.  Back to cited text no. 95
Lebedeva LV, Sokolova GB, Nikolaeva NV, Konovalova RK. Methods of detection and diagnosis of minor forms of tuberculosis in children and adolescents. Probl Tuberk 1974;8:4-7.  Back to cited text no. 96
Chelidze AV, Chernousova TIa, Karpukhina NV, Khorosheva MN, Moiseenko LM. Bronchial status in children, adolescents and young people with elevated tuberculin sensitivity. Probl Tuberk 1982;9:27-30.  Back to cited text no. 97
Palamarchuk GF, Akopov AL, Arseniev AI, Derevianko AV, Nagornaya OA. Bronchoscopy in the Diagnosis and Treatment of Respiratory Diseases. Saint Petersburg: Foliant; 2019.  Back to cited text no. 98
Isaeva LA. Pediatrics. Moscow: Meditsina; 1994.  Back to cited text no. 99
Blokhin BM. Childhood Pulmonology: National Manual. Moscow: Geotar-Media; 2021.  Back to cited text no. 100
Kostina ZI, Balashova NM, Balakireva AI, Gerasimova EV, Ivanovskiĭ VB. Value of various methods of the diagnosis of focal pulmonary tuberculosis. Probl Tuberk 1987;11:28-32.  Back to cited text no. 101
Methodical Recommendations. Endobronchial Methods of Tuberculosis Treatment. Moscow: Ministry of Health of RSFSR; 1982.  Back to cited text no. 102
Aksenova VA, Rozinova NN, Mokhnachevskaia AI, Kravchenko AF. Detection of Tuberculosis in Children and Adolescents with Non-specific Pulmonary Pathology in Public Health Institutions. Moscow: I.M. Sechenov Medical Academy; 2005.  Back to cited text no. 103
Berzner AN, German AK, Kovalenbko BA, Kostrub LA, Li BP. Treatment effectiveness in intrathoracic tuberculosis in children and adolescents and the characteristics of the residual posttuberculosis changes. Probl Tuberk 1988;1:32-4.  Back to cited text no. 104
Filippov VP, Chernichenko NV. Bronchoscopy in Pulmonary Diseases. Moscow: Binom; 2014.  Back to cited text no. 105
Chernekhovskaia NE, Andreev VG, Povaliaev AV. Therapeutic Bronchoscopy in the Complex Therapy of Respiratory Organs. 2nd ed. Moscow: Medpress-Inform; 2011.  Back to cited text no. 106
Svistunov BD, Svistunova AS. Endoscopic technologies in phthisiology. Tuberculosis and socially significant diseases 2015;3:25-8. Available from: http://in-tub.ru/storage/app/media/online-magazine/3-2015.pdf. [Last accessed on 2021 Nov 14].  Back to cited text no. 107
Sobkin AL. To the 100 anniversary of the state institution of Moscow healthcare “Prof. G.A. Zakhar' in Tuberculosis clinical hospital.” Tuberk Bolezn Legk 2014;9:97-9.  Back to cited text no. 108
Kazantsev VA. Abstract 1358. The use of bronchological sanation for treatment of community-acquired pneumonia. In: Abstract Book. 3rd Congress of European Region, International Union against Tuberculosis and Lung Diseases (IUATLD), 14th National Congress of Lung Diseases. Moscow: Russian Respiratory Society; 2004. p. 361.  Back to cited text no. 109
Iakovlev GM, Kazantsev VA. Clinico-immunological characteristics and prevention of recurrent acute pneumonias. Voen Med Zh 1987;11:38-9.  Back to cited text no. 110
Iakovlev GM, Kazantsev VA. Clinico-immunological characteristics of acute pneumonia in young patients. Ter Arkh 1988;60:57-60.  Back to cited text no. 111
Rakov AL, Komarevtsev VN, Kharitonov MA, Kazantsev VA. Characteristics of community-acquired pneumonia in servicemen during the military conflict on the Northern Caucasus in 1995-1996. Voen Med Zh 2005;326:23-30, 80.  Back to cited text no. 112
Jargin SV. Bronchoscopy in children for research with questionable indications: An overview of Russian patents and publications. Recent Pat Drug Deliv Formul 2017;11:83-8.  Back to cited text no. 113
Quaiser S, Agarwal A, Khan R, Haque SF. Fiberoptic bronchoscopy, as a valuable diagnostic option in sputum negative pulmonary tuberculosis: A prospective study. Int J Appl Basic Med Res 2012;2:123-7.  Back to cited text no. 114
Mondoni M, Repossi A, Carlucci P, Centanni S, Sotgiu G. Bronchoscopic techniques in the management of patients with tuberculosis. Int J Infect Dis 2017;64:27-37.  Back to cited text no. 115
Shahzad T, Irfan M. Endobronchial tuberculosis-a review. J Thorac Dis 2016;8:3797-802.  Back to cited text no. 116
Khan EA, Starke JR. Diagnosis of tuberculosis in children: Increased need for better methods. Emerg Infect Dis 1995;1:115-23.  Back to cited text no. 117
Feinsilver SH, Fein A. Textbook of Bronchoscopy. Baltimore: Williams & Wilkins; 1995.  Back to cited text no. 118
McIntosh N, Helms PJ, Smyth RL. Forfar & Arneil's textbook of pediatrics: 6th edition. J R Soc Med 2004;97:96.  Back to cited text no. 119
García AT, de Agüero MI, Carrasco CM, Landeira CA, Dorado RD, del Castillo F, et al. Fibrobroncoscopia en la tuberculosis endobronquial. An Pediatr (Barc) 2004;61:314-9.  Back to cited text no. 120
Donato L, Helms P, Barats A, Lebris V. Endoscopie bronchique et tuberculose de l'enfant. Arch Pediatr 2005;12 Suppl 2:S127-31.  Back to cited text no. 121
Somu N, Swaminathan S, Paramasivan CN, Vijayasekaran D, Chandrabhooshanam A, Vijayan VK, et al. Value of bronchoalveolar lavage and gastric lavage in the diagnosis of pulmonary tuberculosis in children. Tuber Lung Dis 1995;76:295-9.  Back to cited text no. 122
Barnes D, Gutiérrez Chacoff J, Benegas M, Perea RJ, de Caralt TM, Ramirez J, et al. Central airway pathology: Clinic features, CT findings with pathologic and virtual endoscopy correlation. Insights Imaging 2017;8:255-70.  Back to cited text no. 123
Revel MP, Fournier LS, Hennebicque AS, Cuenod CA, Meyer G, Reynaud P, et al. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol 2002;179:1217-24.  Back to cited text no. 124
McWilliams T, Wells AU, Harrison AC, Lindstrom S, Cameron RJ, Foskin E. Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis. Thorax 2002;57:1010-4.  Back to cited text no. 125
Barut S, Erkorkmaz U, Yüce S, Uyetürk U. Analysis of risk factors in anti-HCV positive patients in Gaziosmanpasa University Hospital, Tokat, Turkey. Mikrobiyol Bul 2008;42:675-80.  Back to cited text no. 126
Kulakova AV, Kokina NI, Kogan EA, Ablitsov YM, Pavlov CS, Zeliger LR, et al. Abstract 46. Peculiarities of therapy in patients with tuberculosis associated to viral hepatitis. In: Abstract Book. 3rd Congress of European Region, International Union against Tuberculosis and Lung diseases (IUATLD), 14th National Congress of Lung Diseases. Moscow: Russian Respiratory Society; 2004. p. 16.  Back to cited text no. 127
Asratian AA, Danilina GA, Kozhevnikova LK, Marina-Fedorova RF, Zotova IO. Serologic markers of hepatitis B in patients at a tuberculosis hospital. Probl Tuberk 1989;4:36-8.  Back to cited text no. 128
Larson JL, Lambert L, Stricof RL, Driscoll J, McGarry MA, Ridzon R. Potential nosocomial exposure to Mycobacterium tuberculosis from a bronchoscope. Infect Control Hosp Epidemiol 2003;24:825-30.  Back to cited text no. 129
Ramsey AH, Oemig TV, Davis JP, Massey JP, Török TJ. An outbreak of bronchoscopy-related Mycobacterium tuberculosis infections due to lack of bronchoscope leak testing. Chest 2002;121:976-81.  Back to cited text no. 130
Hanson PJ, Jeffries DJ, Batten JC, Collins JV. Infection control revisited: Dilemma facing today's bronchoscopists. BMJ 1988;297:185-7.  Back to cited text no. 131
Mehta AC, Minai OA. Infection control in the bronchoscopy suite. A review. Clin Chest Med 1999;20:19-32, ix.  Back to cited text no. 132
Jargin SV. Surfactant preparations for tuberculosis and other diseases beyond infancy: A letter from Russia. Tuberculosis (Edinb) 2012;92:280-2.  Back to cited text no. 133
Jargin SV. Surfactant therapy of pulmonary conditions excluding those with primary surfactant deficiency and bronchoscopy as delivery method: An overview of Russian patents and publications. Recent Pat Drug Deliv Formul 2013;7:134-7.  Back to cited text no. 134
Jargin SV. The use of surfactant preparations in the absence of primary deficiency: Publications, legal and regulatory framework. GlavVrach – Chief Medical Officer 2021;1:40-50. Available from: https://www.elibrary.ru/item.asp?id=44744924. [Last accessed on 2021 Nov 14].  Back to cited text no. 135
Jargin SV. Pulmonary surfactant preparations in the absence of its primary deficiency: A physicist's view. Molodoi Uchenyi-Young Scientist 2013;5:870-3. Available from: https://moluch.ru/archive/52/6880/. [Last accessed on 2021 Nov 14].  Back to cited text no. 136
Rozenberg OA, Seiliev AA. Method for obtaining surfactant from bovine lungs. Patent RU2691648C1 (2019). Available from: https://patents.google.com/patent/RU2691648C1/en?oq=RU2691648C1. [Last accessed on 2021 Nov 14].  Back to cited text no. 137
Fujiwara T, Robertson B. Pharmacology of exogenous surfactant. In: Robertson B, van Golde LM, Batenburg JJ, editors. Pulmonary Surfactant. From Molecular Biology to Clinical Practice. Amsterdam: Elsevier; 1992. p. 561-92.  Back to cited text no. 138
Erpenbeck VJ, Hagenberg A, Dulkys Y, Elsner J, Bälder R, Krentel H, et al. Natural porcine surfactant augments airway inflammation after allergen challenge in patients with asthma. Am J Respir Crit Care Med 2004;169:578-86.  Back to cited text no. 139
Rozenberg OA. Pulmonary surfactant preparations and surfactant therapy for ARDS in surgical intensive care (a literature review). Creat Surg Oncol 2019;9:50-65. [doi: 10.24060/2076-3093-20199-1-50-65].  Back to cited text no. 140
Bautin AE, Avdeev SN, Seyliev AA, Shvechkova MV, Merzhoeva ZM, Trushenko NV, et al. Inhalation surfactant therapy in the integrated treatment of severe COVID-19 pneumonia. Tuberk Bolezn Legk 2020;98:6-12.  Back to cited text no. 141
Granov AM, Rozenberg OA, Tsybul'kin EK, Erokhin VV, Khubulava GG, Likhvantsev VV, et al. Critical state medicine. Surfactant therapy of adult respiratory distress syndrome (results of multicenter studies). Vestn Ross Akad Med Nauk 2001;5:34-8.  Back to cited text no. 142
Bautin A, Khubulava G, Kozlov I, Poptzov V, Osovskikh V, Seiliev A, et al. Surfactant therapy for patients with ARDS after cardiac surgery. J Liposome Res 2006;16:265-72.  Back to cited text no. 143
Tsybul'kin EK, Rozenberg OA, Seĭliev AA, Volchkov VA, Zaĭtseva NV, Kuz'menko IG, et al. Our experience in the use of a Russian preparation of pulmonary surfactant in the treatment of acute respiratory distress syndrome and severe pneumonia in children. Anesteziol Reanimatol 1999;2:61-5.  Back to cited text no. 144
Bautin AE, Khubulava GG, Fadeev AA, Rozenberg OA. The first experience with using a preparation of lung surfactant for prevention and treatment of the acute lung injury syndrome after operations on the heart and aorta. Vestn Khir Im I I Grek 2003;162:79-83.  Back to cited text no. 145
Kozlov IA, Poptsov VN. Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients. Anesteziol Reanimatol 2005;6:38-41.  Back to cited text no. 146
Kozlov IA, Poptsov VN. Combined therapy with nitric oxide and Surfactant-BL for acute respiratory distress syndrome after operations using extracorporeal circulation. Obshtshaia Reanimatologiia 2005;1:15-9.  Back to cited text no. 147
Pochepen ON, Zolotuhina LV, Zemec EA, Markevich MN, Troyanovskiy ES. The use of Surfactant-BL in treatment of inhalation injury after severe burns. Skoraia Meditsinskaia Pomoshtsh 2011;12:44-7.  Back to cited text no. 148
Lepekha LN. Pulmonary surfactant system in experimental tuberculous inflammation and evaluation of its morpho-functional condition in humans. In: Doctoral Dissertation. Moscow: Research Institute of Human Morphology; 1995.  Back to cited text no. 149
Lovacheva OV, Erokhin VV, Chernichenko NV, Evgushchenko GV, Lepekha LN, Rozenberg OA. Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis. Probl Tuberk Bolezn Legk 2006;10:12-7.  Back to cited text no. 150
Ministry of Health of Russian Federation. A/H1N1 influenza and the corresponding pneumonia in pregnant women. Etiotropic and respiratory therapy. Information Lett Nr 24-5/10/2-9533 of November 28, 2009.  Back to cited text no. 151
BIOSURF. Instruction for Medical Use of SURFACTANT-BL, Registration No. 003383/01-230710. Available from: https://biosurf.ru/doctor/. [Last accessed on 2021 Nov 14].  Back to cited text no. 152
Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:1309-15.  Back to cited text no. 153
Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992;18:319-21.  Back to cited text no. 154
Erokhin VV, Romanova LK. Pulmonary surfactant system. In: Erokhin VV, Romanova LK, editors. Pulmonary Cell Biology in the Norm and Pathology. Moscow: Meditsina; 2000. p. 167-81.  Back to cited text no. 155
Sweet DG, Turner MA, Straňák Z, Plavka R, Clarke P, Stenson BJ, et al. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 2017;102:F497-503.  Back to cited text no. 156
Rozenberg ОА. Pulmonary surfactants for acute and chronic lung diseases (Part II). Gen Reanimatol 2014;10:69-86. [doi: 10.15360/1813-9779-2014-5-69-86].  Back to cited text no. 157
Oetomo SB, Dorrepaal C, Bos H, Gerritsen J, van der Mark TW, Koëter GH, et al. Surfactant nebulization does not alter airflow obstruction and bronchial responsiveness to histamine in asthmatic children. Am J Respir Crit Care Med 1996;153:1148-52.  Back to cited text no. 158
Zhemkov VF, Ivanovsky VB, Zhemkova MV, Seiliev AA, Volchkov VA, Rozenberg OA. Use of natural lung surfactant in the combination treatment of pulmonary tuberculosis. Probl Tuberk Bolezn Legk 2013;2:18-22.  Back to cited text no. 159
Rozenberg ОА. Pulmonary surfactants for acute and chronic lung diseases (Part I). Gen Reanimatol 2014;10:51-73.  Back to cited text no. 160
Hohlfeld JM. The role of surfactant in asthma. Respir Res 2002;3:4.  Back to cited text no. 161
Erokhin VV, Lepekha LN, Erokhina MV, Lovacheva OV. The Surfactant System in Pulmonary Tuberculosis. Moscow: Central Tuberculosis Research Institute; 2013.  Back to cited text no. 162
Erokhin VV, Lovacheva OV, Lepekha LN, Rozenberg OA, Seiliev AA, Volchkov VA. Pulmonary tuberculosis treatment method. Patent RU2195313C1 (2002). Available from: https://patents.google.com/patent/RU2195313C1/en?oq=RU2195313C1. [Last accessed on 2021 Nov 14].  Back to cited text no. 163
Erokhin VV, Vasil'eva IA, Konopliannikov AG, Chukanov VI, Tsyb AF, Bagdasarian TR, et al. Systemic transplantation of autologous mesenchymal stem cells of the bone marrow in the treatment of patients with multidrug-resistant pulmonary tuberculosis. Probl Tuberk Bolezn Legk 2008;10:3-6.  Back to cited text no. 164
Erokhin VV, Tsyb AF, Chukanov VI, Vasil'eva IA, Bagdasarian TR, Konopliannikov AG, et al. Cellular technologies in therapy for chronic multidrug-resistant pulmonary tuberculosis. Probl Tuberk Bolezn Legk 2006;8:3-5.  Back to cited text no. 165
Fedorov IA, Wilson SJ, Davies DE, Holgate ST. Epithelial stress and structural remodelling in childhood asthma. Thorax 2005;60:389-94.  Back to cited text no. 166
Neill SJ. Research with children: A critical review of the guidelines. J Child Health Care 2005;9:46-58.  Back to cited text no. 167
Kuther TL, Posada M. Children and adolescents' capacity to provide informed consent for participation in research. Adv Psychol Res 2004;32:163-73.  Back to cited text no. 168
Murphy J, Jargin S. International trends in health science librarianship part 20: Russia. Health Info Libr J 2017;34:92-4.  Back to cited text no. 169


  [Figure 1]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
Surgical Treatment
The Comorbidity ...
Compulsory Hospi...
Surfactant Therapy
Article Figures

 Article Access Statistics
    PDF Downloaded132    
    Comments [Add]    

Recommend this journal